INS and type 2 diabetes mellitus: In conclusion, our study finds that GLP-1RAs and other non-insulin antidiabetic medications are associated with a lower risk of LC in patients with T2DM compared with insulins, providing information to guide clinicians in the selection of appropriate therapies for individuals with T2DM while mitigating the risk of developing LC.